Quick Answer
Werewolf Therapeutics, Inc. reported Total Assets of $69.40 million for fiscal year 2025.
Werewolf Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $69.40M | -45.3% |
| 2024 | $126.93M | -27.4% |
| 2023 | $174.83M | +9.1% |
| 2022 | $160.25M | -10.6% |
| 2021 | $179.25M | +85.9% |
| 2020 | $96.40M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $79.63M | -43.1% | -14.0% |
| June 30, 2025 | $92.57M | -39.8% | -13.7% |
| March 31, 2025 | $107.24M | -39.6% | -15.5% |
| December 31, 2024 | $126.93M | -27.4% | -9.4% |
| September 30, 2024 | $140.04M | -20.6% | -8.9% |
| June 30, 2024 | $153.70M | -17.0% | -13.5% |
| March 31, 2024 | $177.60M | -9.0% | +1.6% |
| December 31, 2023 | $174.83M | +9.1% | -0.9% |
- Werewolf Therapeutics, Inc. showed a decrease of -45.3% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Werewolf Therapeutics, Inc.’s total assets has declined by 28.0% (from $96.40 million to $69.40 million).
- The most recent figure is from Werewolf Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: